IMV INC
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch IMV INC and buy or sell other stocks, ETFs, and their options commission-free!About IMVIF
IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response.
CEOAndrew Hall
CEOAndrew Hall
Employees—
Employees—
HeadquartersDartmouth, Nova Scotia
HeadquartersDartmouth, Nova Scotia
Founded2007
Founded2007
Employees—
Employees—
IMVIF Key Statistics
Market cap23.42K
Market cap23.42K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume277.90
Average volume277.90
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.0195
52 Week high$0.0195
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
The current IMV INC(IMVIF) stock price is $0.00, with a market capitalization of 23.42K.
On 2026-05-08, IMV INC(IMVIF) stock opened at —, reached a high of —, and a low of —.
The IMV INC(IMVIF)'s current trading volume is 0, compared to an average daily volume of 277.9.
In the last year, IMV INC(IMVIF) shares hit a 52-week high of $0.02 and a 52-week low of $0.00.
In the last year, IMV INC(IMVIF) shares hit a 52-week high of $0.02 and a 52-week low of $0.00.
People also own
Based on the portfolios of people who own IMVIF. This list is generated using Robinhood data, and it’s not a recommendation.